People | October 04, 2022
Matt Sause elevated as new CEO of Roche Diagnostics
Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.
Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
The new assay consolidates screening for four major viral threats into a single workflow
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
Roche says its new assay “resolves this challenge by delivering accurate and specific results
The PCR-based test, delivered via Roche’s cobas liat system, allows results to be obtained during a patient consultation in GP practices and Emergency Rooms
Test delivers results in just 18 minutes, enabling faster laboratory workflows and patient management during outbreaks
The new algorithm will be introduced as part of Roche’s CKD Algorithm Panelon thenavify Algorithm Suite
Roche also shared the design of its upcoming Phase III TRONTIER 1 and 2 trials investigating trontinemab in people with early symptomatic Alzheimer’s disease
Subscribe To Our Newsletter & Stay Updated
